The Indian Prime Minister Manmohan Singh has been requested by doctors, HIV-positive people and non-governmental organizations in India to ensure India's participation in the international drug purchasing facility UNITAID.
UNITAID was formed in September 2006 by France and 19 other nations that have set aside a portion of their airline tax revenues for programs in developing countries. At least 34 countries have signed up as donors to UNITAID. The $300 million fund aims to provide antiretroviral drugs to an additional 100,000 HIV-positive children worldwide this year, as well as to increase access to drugs for other diseases.
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV
Advertisement
Celina D'Costa of the Indian Network for People Living With HIV/AIDS said that if each airline ticket sold in India could contribute 100 rupees, or about $2.50, "that gives the measure of the kind of money that can be generated to support" development of second-line antiretroviral drugs and second-line drugs for other diseases, such as tuberculosis and malaria.
India aims to achieve universal access to antiretrovirals by 2012; about 700,000 people in the country currently are in need of antiretrovirals but do not have access to the drugs. According to some HIV/AIDS advocates, India does not have the funds in place to support HIV prevention and universal access programs. Stanzin Dawa of the International AIDS Alliance in India asked, "Of what use will ... first-line [antiretrovirals] be if India cannot manage to start [a] second-line" antiretroviral program?.
Source: Kaiser Family Foundation
SRM/S
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV
Advertisement
 Second Line Drugs for HIV and TB Made Available If India Joins UNITAIDIn a significant development addressing the medicinal needs of people living with HIV and TB, UNITAID, a frontal organisation of the United Nations | Advertisement
|
Advertisement
Latest AIDS/HIV News
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
